Most Policy Initiative logo

Biospecimen Confidentiality

March 1, 2021
view pdf
WRITTEN BY Joshua Mueller

Research involving human participants can include the collection of biospecimens, such as blood or tissue, that can be analyzed for diagnostic purposes or evaluation of clinical treatments.

Regulatory requirements at the institutional, state, and federal level provide protections for both the health and privacy of research participants. In particular, current law lays out requirements for informed consent, removal of identifiable information for anonymized study, and confidentiality of health records.

In addition to these standards, HB 995 would require laboratories to obtain consent from individuals before releasing any biological specimen for anonymous scientific study. It would also allow individuals to direct the laboratory to return or destroy the sample upon completion of testing. This bill would apply retroactively. Failing to adhere to this rule would be a class A felony.

Most Policy Initiative logo
238 E High St., 3rd Floor
Jefferson City, MO 65101

© 2021 MOST Policy Initiative | Website design and development by Pixel Jam Digital
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram